药物研发市场中的人工智慧（按治疗领域、应用和地区）

药物研发人工智慧市场规模预计在 2025 年达到 16.99 亿美元，预计到 2032 年将达到 47.441 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 15.8%。

人工智慧 (AI) 是创造智慧机器（尤其是智慧型电脑程式）的科学与工程。 AI 技术几乎可以应用于製药科学的各个方面，包括药物发现、药物开发、药物再利用、药物代谢预测、药物毒性分析、药物生产效率提升以及临床试验。这些技术统称为 AIDD（药物发现中的人工智慧）。

市场动态：

不断进步的技术、市场参与企业的产品研究、合作研究、研发协议以及市场参与企业的其他无机成长策略是预计在预测期内促进全球药物研发市场人工智慧成长的关键因素。

例如，2023年5月16日，Google云端在Bio-IT世界大会上宣布了两款全新的AI驱动生命科学解决方案，旨在加速生物技术公司、製药公司和上市公司的药物发现和精准医疗。标靶和先导化合物识别套件可帮助研究人员识别胺基酸的功能并预测蛋白质结构。多组学套件可加速基因组数据的发现和解读，帮助企业设计精准药物。

本研究的主要特点

• 本报告对全球药物研发人工智慧市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025 年至 2032 年的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
• 该报告涵盖了全球药物研发人工智慧市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、财务表现和策略。
• 报告中的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
• 全球药物研发人工智慧市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过用于分析全球药物研发人工智慧市场的各种策略矩阵来促进其决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 控制药物开发和发现成本的需求日益增加
  • 慢性病的增加促进了个人化医疗的发展
  • 医疗保健和药物研发领域的巨量资料和资讯爆炸
  • 扩大人工智慧在各医疗领域的应用
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

第四章 药物研发市场中的人工智慧—冠状病毒 (COVID-19) 大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年药物研发市场中人工智慧的治疗领域

• 肿瘤学
• 神经退化性疾病
• 心血管疾病
• 代谢疾病
• 感染疾病
• 其他的

6. 人工智慧药物研发市场（按应用划分），2020 年至 2032 年

• 药物优化和再利用
• 临床前试验
• 其他的

7. 2020 年至 2032 年药物研发市场中的人工智慧（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争态势

• IBM Corporation（Ibm Watson Health）
• Exscientia
• GNS Healthcare
• Alphabet, Inc.（DEEPMIND）
• Benevolent AI
• Biosymetrics
• Euretos
• Berg LLC.
• Atomwise, Inc.

第九章 章节

• 调查方法
• 关于出版商

Artificial Intelligence in Drug Discovery Market is estimated to be valued at USD 1,699.0 Mn in 2025 and is expected to reach USD 4,744.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032.

The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).

Market Dynamics:

Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.

For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence in drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.

Detailed Segmentation:

• Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space:
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Other
• Global Artificial Intelligence in Drug Discovery Market, By Application:
  • Drug Optimization & Repurposing
  • Preclinical Testing
  • Others
• Global Artificial Intelligence in Drug Discovery Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • IBM Corporation (Ibm Watson Health)
  • Exscientia
  • GNS Healthcare
  • Alphabet, Inc. (DEEPMIND)
  • Benevolent AI
  • Biosymetrics
  • Euretos
  • Berg LLC.
  • Atomwise, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapeutic Space
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising need to curb drug development and discovery costs
  • Rising prevalence of chronic diseases supporting development of personalized drugs
  • Big data and information explosion in healthcare and drug discovery
  • Growing applications of AI in various healthcare areas
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Artificial Intelligence in Drug Discovery Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Neurodegenerative Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Metabolic Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Artificial Intelligence in Drug Discovery Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Optimization & Repurposing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Preclinical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Artificial Intelligence in Drug Discovery Market, By Geography, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)

8. Competitive Landscape

• IBM Corporation (Ibm Watson Health)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exscientia
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNS Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alphabet, Inc. (DEEPMIND)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Benevolent AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biosymetrics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Euretos
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Berg LLC.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Atomwise, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us